The imino sugar N-butyldeoxynojirimycin (NB-DNJ) is a glucose analogue which inhibits the glycoprotein N-glycan processing enzymes alpha-glucosidases I and II and the ceramide glucosyltransferase that catalyses the first step of glycosphingolipid biosynthesis. This and other N-alkylated DNJ compounds have the potential to inhibit other glucosidase, including acid alpha-glucosidase and alpha-1,6-glucosidase, enzymes involved in glycogen breakdown. We have investigated the effect of NB-DNJ and ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record